Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1995 1
1997 1
1999 1
2000 1
2002 1
2004 2
2005 2
2006 1
2009 1
2011 9
2012 6
2013 9
2014 11
2015 18
2016 14
2017 16
2018 13
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 29040754

109 results
Results by year
Filters applied: . Clear all
Page 1
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.
Gacerez AT, Hua CK, Ackerman ME, Sentman CL. Gacerez AT, et al. Cancer Immunol Immunother. 2018 May;67(5):749-759. doi: 10.1007/s00262-018-2124-1. Epub 2018 Feb 16. Cancer Immunol Immunother. 2018. PMID: 29453518
B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.
Bjørnsen EG, Thiruchelvam-Kyle L, Hoelsbrekken SE, Henden C, Saether PC, Boysen P, Daws MR, Dissen E. Bjørnsen EG, et al. Eur J Immunol. 2019 Jan;49(1):54-65. doi: 10.1002/eji.201847746. Epub 2018 Dec 13. Eur J Immunol. 2019. PMID: 30512185 Free article.
Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
Xu X, Li Y, Gauthier L, Chen Q, Vivier E, Mariuzza RA. Xu X, et al. Acta Crystallogr F Struct Biol Commun. 2015 Jun;71(Pt 6):697-701. doi: 10.1107/S2053230X15006755. Epub 2015 May 20. Acta Crystallogr F Struct Biol Commun. 2015. PMID: 26057798 Free PMC article.
Characterization of B7H6, an endogenous ligand for the NK cell activating receptor NKp30, reveals the identity of two different soluble isoforms during normal human pregnancy.
Gutierrez-Franco J, Hernandez-Gutierrez R, Bueno-Topete MR, Haramati J, Navarro-Hernandez RE, Escarra-Senmarti M, Vega-Magaña N, Del Toro-Arreola A, Pereira-Suarez AL, Del Toro-Arreola S. Gutierrez-Franco J, et al. Immunobiology. 2018 Jan;223(1):57-63. doi: 10.1016/j.imbio.2017.10.012. Epub 2017 Oct 6. Immunobiology. 2018. PMID: 29055565
Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.
Flajnik MF, Tlapakova T, Criscitiello MF, Krylov V, Ohta Y. Flajnik MF, et al. Immunogenetics. 2012 Aug;64(8):571-90. doi: 10.1007/s00251-012-0616-2. Epub 2012 Apr 11. Immunogenetics. 2012. PMID: 22488247 Free PMC article.
HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
Peipp M, Derer S, Lohse S, Staudinger M, Klausz K, Valerius T, Gramatzki M, Kellner C. Peipp M, et al. Oncotarget. 2015 Oct 13;6(31):32075-88. doi: 10.18632/oncotarget.5135. Oncotarget. 2015. PMID: 26392331 Free PMC article.
Synergistic capture of Clostridium botulinum type A neurotoxin by scFv antibodies to novel epitopes.
Gray SA, Barr JR, Kalb SR, Marks JD, Baird CL, Cangelosi GA, Miller KD, Feldhaus MJ. Gray SA, et al. Biotechnol Bioeng. 2011 Oct;108(10):2456-67. doi: 10.1002/bit.23196. Epub 2011 May 12. Biotechnol Bioeng. 2011. PMID: 21538339 Free PMC article.
109 results
Jump to page